Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent vs Continuous IV Pantoprazole for Peptic Ulcer Bleeding
NCT03814421Unknown
- Sponsor
- Samsung Changwon Medical Center
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pantoprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by Samsung Changwon Medical Center. Primary endpoint: Rebleeding rates within 7 days. Status: unknown.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT03814421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814421.